Framingham Heart Study

This study has been completed.

First Received on May 25, 2000. Last Updated on April 13, 2009 History of Changes

Sponsor:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00005121

Purpose

The Framingham Heart Study was initiated to study the factors associated with the development of cardiovascular disease by employing long-term surveillance of an adult population in Framingham, Massachusetts. The Framingham Offspring Study was initiated to assess familial and genetic factors as determinants of coronary heart disease.

Condition
Cardiovascular Diseases Heart Diseases Coronary Disease Cerebrovascular Accident Hypertension Heart Failure, Congestive Peripheral Vascular Diseases Arterial Occlusive Diseases Atherosclerosis Heart Failure

Study Type:

Observational

Resource links provided by NLM:

MedlinePlus related topics: Atherosclerosis Coronary Artery Disease Heart Diseases Heart Failure High Blood Pressure Peripheral Arterial Disease Vascular Diseases

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:	July 1948
Study Completion Date:	September 2008
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)

Show Detailed Description

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

No eligibility criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005121

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Investigator:

Philip Wolf

Boston University

More Information

Additional Information:

Related Info This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier:	NCT00005121 History of Changes
Other Study ID Numbers:	900
Study First Received:	May 25, 2000
Last Updated:	April 13, 2009
Health Authority:	United States: Federal Government

Additional relevant MeSH terms:

Arterial Occlusive Diseases
Atherosclerosis
Cardiovascular Diseases
Coronary Disease
Coronary Artery Disease
Heart Diseases
Heart Failure
Hypertension
Cerebral Infarction
Stroke
Vascular Diseases

Peripheral Vascular Diseases
Peripheral Arterial Disease
Arteriosclerosis
Myocardial Ischemia
Brain Infarction
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on February 09, 2012